Andrew M Glenn

Title: The Innovations of Andrew M Glenn

Introduction

Andrew M Glenn is an accomplished inventor based in Germantown, MD (US). He has made significant contributions to the field of immunology, particularly through his innovative work on vaccines. His expertise and dedication have led to the development of a notable patent that addresses critical health challenges.

Latest Patents

Andrew M Glenn holds a patent titled "Immunogenicity of a CpG-adjuvanted recombinant plague vaccine." This patent relates to immunogenic compositions that comprise at least one antigen, an aluminum salt adjuvant, and an oligonucleotide featuring an unmethylated cytidine-phospho-guanosine (CpG) motif. The compositions are designed to stimulate an immune response in subjects who require it. Additionally, the patent includes methods and kits that utilize these immunogenic compositions.

Career Highlights

Throughout his career, Andrew has worked with prominent organizations, including Dynavax Technologies Corporation and the U.S. Government as represented by the Secretary of the Army. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Andrew M Glenn has collaborated with notable colleagues such as Robert S Janssen and David Novack. These partnerships have further enhanced his research and development efforts in the field of immunology.

Conclusion

Andrew M Glenn's contributions to vaccine development and immunology are noteworthy. His innovative patent and collaborations reflect his commitment to advancing health solutions. His work continues to impact the scientific community positively.